When it comes to human capital, "risk" and "uncertainty" are two different concepts, and they need to be addressed separately in order to minimize risk.
However, employers' disdain for several aspects of the law, and their wish for changes to it, remain intact.
The rate of spending increase on high-tech pharmaceuticals will top 17% for a second consecutive year, a study says.
A "total return swap" isn't a common way to hedge the volatility of non-qualified deferred compensation (NQDC) plans, but it's the most effective method.
While millions would become uninsured if the bill became law, group health plans would mostly benefit, observers say.
Consumer-directed health plans may not become as ubiquitous as once thought, survey results suggest.
Millions of newly uninsured could cause a spike in costs for health-care providers, who likely would pass the costs on to private payers.
The average increase was only 2.4%, a historically low rate, according to Mercer data.
Following this week's elections, CFOs are again in the dark about the outlook for the cost, delivery, and quality of company-sponsored health care.
A Mercer survey finds 59% of large U.S. firms cover a telemedicine program, compared with 30% in 2015.
Research suggests the average ratio between CEO compensation and that of a typical worker is closer to 200:1 than the widely reported 300:1.
A Mercer survey finds the funded status of S&P 1500 plans dropped to 76% after the U.K.'s vote to leave the EU.
